The Knight Cancer Institute at Portland-based Oregon Health & Science University has appointed Joel Helmke as CEO of the Knight Cancer Group.
The Knight Cancer Group — established through a $2 billion donation from Phil and Penny Knight — will govern the Knight Cancer Institute’s new care model and manage OHSU’s cancer services.
Mr. Helmke will step into the role in mid-March after serving as COO of Philadelphia-based Fox Chase Cancer Center since 2021, according to a Jan. 26 news release from the university.
He has previously served as senior vice president of clinical operations at Duarte, Calif.-based City of Hope and as system vice president for Marietta, Ga.-based WellStar Cancer Network. He spent 14 years of his career at Houston-based University of Texas MD Anderson Cancer Center, including as executive director and division administrator of internal medicine.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
